Porvair’s (PRV) “Hold” Rating Reaffirmed at Shore Capital

Shore Capital reaffirmed their hold rating on shares of Porvair (LON:PRVFree Report) in a report released on Monday morning, MarketBeat.com reports.

Separately, Berenberg Bank started coverage on Porvair in a research note on Thursday, May 16th. They set a buy rating and a GBX 800 ($10.12) price objective for the company.

View Our Latest Analysis on Porvair

Porvair Trading Up 1.6 %

Shares of PRV opened at GBX 640 ($8.10) on Monday. The stock’s fifty day simple moving average is GBX 659.48 and its 200-day simple moving average is GBX 641.91. The firm has a market capitalization of £296.70 million, a PE ratio of 1,828.57 and a beta of 0.76. Porvair has a 12-month low of GBX 522 ($6.60) and a 12-month high of GBX 745.70 ($9.43). The company has a quick ratio of 1.22, a current ratio of 2.22 and a debt-to-equity ratio of 11.52.

Porvair Cuts Dividend

The company also recently declared a dividend, which will be paid on Wednesday, August 21st. Stockholders of record on Thursday, July 18th will be issued a GBX 2.10 ($0.03) dividend. This represents a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, July 18th. Porvair’s dividend payout ratio (DPR) is 1,714.29%.

Insider Buying and Selling

In other Porvair news, insider James Mills acquired 4,250 shares of the business’s stock in a transaction dated Friday, April 19th. The shares were acquired at an average price of GBX 620 ($7.84) per share, for a total transaction of £26,350 ($33,329.12). 22.91% of the stock is currently owned by company insiders.

Porvair Company Profile

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications.

See Also

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.